- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT00578604
Non-Invasive Assessment of Wound Healing With Optical Methods
28. marts 2017 opdateret af: Drexel University College of Medicine
The objective of this project is to further the development of a non-invasive optically based NIR (Near Infrared) device to enable the quantitative diagnosis, monitoring and treatment optimization of chronic wounds (especially diabetic) in a clinical setting.
The end goal of this project is a portable and compact device that would be simple to operate by minimally trained health care personnel.
Our animal studies have shown that the early healing of chronic wounds can be characterized by absorption and scattering of light at near infrared wavelengths ranging from 680 nm to 950 nm.
If our project is successful we will be providing the clinician the ability to predict if a wound is healing and if a particular treatment is successful in accelerating healing before any changes are observed by wound size contraction or other visible clinical signs.
Our hope is that the fNIR optical device will provide conclusive therapeutic treatment information as early as 5 weeks after initial evaluation, before it would be obvious on gross examination of the patient.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Undersøgelsestype
Observationel
Tilmelding (Faktiske)
38
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Forenede Stater, 19102
- Drexel University College of Medicine Wound Care Center
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år til 65 år (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Prøveudtagningsmetode
Ikke-sandsynlighedsprøve
Studiebefolkning
Recruited patients will be patients with diabetes who have chronic wounds and will likely have other co-morbidities associated with chronic diabetes.
Control subjects do not have diabetes and do not have wounds.
Beskrivelse
Healthy Subject inclusion criteria
- Subjects must be 18-65 years of age
- Subjects must have no history of diabetes
- Subjects must have no history of vascular disease
- Subjects must have no findings of vascular disease on physical examination
- Subjects who are not allergic to Tegaderm
Patient Subject inclusion criteria:
- Subjects must be 18-65 years of age
- Subjects must have documented diabetes mellitus for at least 6 months.
- Subjects must have at least one documented chronic wound for a minimum 8 weeks.
- A chronic wound is defined as any wound that has not healed after 8 weeks and has a minimum surface area of 1cm2. There is no maximum wound size.
- Wound(s) must be secondary to the complications of diabetes, including vascular disease neuropathy, or both.
- Wounds must be on the ankles or feet
- Subjects who are not allergic to Tegaderm
EXCLUSION CRITERIA
- Subject must not be <18 or >65 years of age
- Subjects with major infections, abscesses, or untreated osteomyelitis will be excluded until appropriately treated.
- Subjects will not be excluded based upon the existence of other co-morbidities associated with chronic diabetes, including retinopathy, nephropathy, peripheral neuropathy, or cardiovascular disease except as follows:
- Subjects who have moderate to severe vascular insufficiency (defined as ankle brachial index <0.75 or toe-brachial index <0.5)
- Subjects who are unable to return for weekly follow-up appointments will not be included.
- Pregnant or lactating people will not be invited to participate.
- Subjects who are allergic to Tegaderm
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: Kohorte
- Tidsperspektiver: Fremadrettet
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
|---|---|
|
Patients with a diabetic wound
|
Measure blood flow to diabetic wounds
|
|
Control
Patients without a diabetic wound
|
Measure blood flow to diabetic wounds
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
diffuse near infrared spectroscopy measurements
Tidsramme: 3 years
|
The end goal of this project is a portable and compact device that would be simple to operate by minimally trained health care personnel and is comparable to SOC doppler.
|
3 years
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Efterforskere
- Ledende efterforsker: Michael S Weingarten, M.D., Drexel University College of Medicine
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. september 2007
Primær færdiggørelse (Faktiske)
1. juni 2014
Studieafslutning (Faktiske)
1. juni 2014
Datoer for studieregistrering
Først indsendt
20. december 2007
Først indsendt, der opfyldte QC-kriterier
20. december 2007
Først opslået (Skøn)
21. december 2007
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
30. marts 2017
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
28. marts 2017
Sidst verificeret
1. marts 2017
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 17035
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .